Daiichi Sankyo Co., Ltd. – Sponsored ADR (OTCMKTS:DSNKY – Get Free Report) gapped down prior to trading on Wednesday . The stock had previously closed at $22.33, but opened at $21.6960. Daiichi Sankyo shares last traded at $21.4050, with a volume of 56,682 shares trading hands.
Wall Street Analysts Forecast Growth
Separately, Zacks Research lowered shares of Daiichi Sankyo from a “hold” rating to a “strong sell” rating in a report on Wednesday, November 19th. One investment analyst has rated the stock with a Strong Buy rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy”.
Get Our Latest Stock Report on DSNKY
Daiichi Sankyo Stock Performance
About Daiichi Sankyo
Daiichi Sankyo Co, Ltd. is a global, research-driven pharmaceutical company headquartered in Tokyo, Japan. The company was formed through the merger of Daiichi Pharmaceutical and Sankyo in 2005 and focuses on the discovery, development, manufacturing and commercialization of prescription medicines. Its therapeutic priorities include oncology and cardiovascular disease, and it pursues a mix of small molecules, biologics and antibody‑drug conjugates in its development programs.
Daiichi Sankyo is known for building a development portfolio through both internal research and collaborative partnerships.
Further Reading
- Five stocks we like better than Daiichi Sankyo
- Punch these codes into your ordinary brokerage account
- Do not delete, read immediately
- More than 2 million ounces defined – and still early in their story
- If You Keep Cash In A U.S. Bank Account… Read This NOW
- What Expenses Can Be Deducted From Capital Gains Tax?
Receive News & Ratings for Daiichi Sankyo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Daiichi Sankyo and related companies with MarketBeat.com's FREE daily email newsletter.
